Microinfusion: clinical and cost-containment concepts

Area of Science:

• Pharmacology
• Medical Devices
• Health Economics

Background:

• Traditional gravity-controlled intravenous drug delivery systems have inherent limitations.
• Advancements in technology have led to the development of microinfusion systems for controlled drug administration.
• Current systems face challenges including bacterial contamination, phlebitis, embolization, and fluid overload.

Purpose of the Study:

• To describe the concepts and advantages of microinfusion systems for drug delivery.
• To highlight the clinical benefits of microinfusion technology.
• To analyze the financial considerations and cost-effectiveness of implementing microinfusion systems.

Main Methods:

• Overview of microinfusion technology as controlled delivery of small volumes of concentrated drug solutions.
• Description of clinical advantages, including reduced infection and improved drug accuracy.
• Delineation of financial considerations, supply costs, and overall patient care expenses.

Main Results:

• Microinfusion systems demonstrate reduced incidences of bacterial contamination, phlebitis, embolization, and fluid overload.
• Enhanced accuracy in drug delivery is a key clinical advantage.
• Financial benefits include decreased supply costs and lower overall patient care costs.

Conclusions:

• Microinfusion represents a more rational and effective approach to intravenous drug delivery for many patient populations.
• The clinical and financial advantages support increased utilization of microinfusion systems.
• Further exploration and implementation of microinfusion technology are recommended.